TW201309637A - 新穎的查酮或二氫查酮之單萜衍生物及其作為除色素劑的用途 - Google Patents
新穎的查酮或二氫查酮之單萜衍生物及其作為除色素劑的用途 Download PDFInfo
- Publication number
- TW201309637A TW201309637A TW101101715A TW101101715A TW201309637A TW 201309637 A TW201309637 A TW 201309637A TW 101101715 A TW101101715 A TW 101101715A TW 101101715 A TW101101715 A TW 101101715A TW 201309637 A TW201309637 A TW 201309637A
- Authority
- TW
- Taiwan
- Prior art keywords
- extract
- skin
- cosmetic
- formula
- lindera
- Prior art date
Links
- 239000007854 depigmenting agent Substances 0.000 title claims abstract description 7
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 title abstract description 27
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 title abstract description 27
- 150000002773 monoterpene derivatives Chemical class 0.000 title abstract description 3
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 title abstract 2
- 235000005513 chalcones Nutrition 0.000 title abstract 2
- 239000000284 extract Substances 0.000 claims description 49
- 239000002537 cosmetic Substances 0.000 claims description 40
- 239000000203 mixture Substances 0.000 claims description 38
- 241000196324 Embryophyta Species 0.000 claims description 28
- 210000004209 hair Anatomy 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 12
- 239000000419 plant extract Substances 0.000 claims description 12
- 208000012641 Pigmentation disease Diseases 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 11
- 239000004480 active ingredient Substances 0.000 claims description 10
- 230000019612 pigmentation Effects 0.000 claims description 9
- 241000606344 Mitrella <gastropod> Species 0.000 claims description 7
- 244000302909 Piper aduncum Species 0.000 claims description 7
- 238000004061 bleaching Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 241000546273 Lindera <angiosperm> Species 0.000 claims description 6
- 241000671744 Piper hostmannianum Species 0.000 claims description 6
- 238000005282 brightening Methods 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 238000003786 synthesis reaction Methods 0.000 claims description 6
- 241000131322 Helichrysum gymnocephalum Species 0.000 claims description 5
- 244000160860 Mitrella kentii Species 0.000 claims description 5
- 241000722363 Piper Species 0.000 claims description 5
- 239000000049 pigment Substances 0.000 claims description 5
- 241000146029 Lindera aggregata Species 0.000 claims description 4
- 244000245109 Lindera glauca Species 0.000 claims description 4
- 240000006806 Piper hispidum Species 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 230000002500 effect on skin Effects 0.000 claims description 4
- 206010008570 Chloasma Diseases 0.000 claims description 3
- 235000001577 Lindera glauca Nutrition 0.000 claims description 3
- 208000003351 Melanosis Diseases 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 241000208838 Asteraceae Species 0.000 claims description 2
- 238000005119 centrifugation Methods 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 208000031066 hyperpigmentation of the skin Diseases 0.000 claims description 2
- 241000608894 Helichrysum Species 0.000 claims 2
- 238000000227 grinding Methods 0.000 claims 1
- 238000003306 harvesting Methods 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 150000002576 ketones Chemical class 0.000 description 25
- 210000003491 skin Anatomy 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 108060008724 Tyrosinase Proteins 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 241000604893 Lindera umbellata Species 0.000 description 9
- 102000003425 Tyrosinase Human genes 0.000 description 9
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- 235000016761 Piper aduncum Nutrition 0.000 description 8
- 150000003505 terpenes Chemical class 0.000 description 8
- 235000007586 terpenes Nutrition 0.000 description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 6
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 6
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 6
- 230000008099 melanin synthesis Effects 0.000 description 6
- GTCAXTIRRLKXRU-UHFFFAOYSA-N methyl carbamate Chemical compound COC(N)=O GTCAXTIRRLKXRU-UHFFFAOYSA-N 0.000 description 6
- 235000005875 quercetin Nutrition 0.000 description 6
- 229960001285 quercetin Drugs 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 5
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 5
- 230000037307 sensitive skin Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- 241001131629 Lancea Species 0.000 description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 235000002566 Capsicum Nutrition 0.000 description 3
- 244000004281 Eucalyptus maculata Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000006002 Pepper Substances 0.000 description 3
- 235000017804 Piper guineense Nutrition 0.000 description 3
- 235000008184 Piper nigrum Nutrition 0.000 description 3
- 244000309464 bull Species 0.000 description 3
- 229910000420 cerium oxide Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000035614 depigmentation Effects 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 229930003949 flavanone Natural products 0.000 description 3
- 150000002208 flavanones Chemical class 0.000 description 3
- 235000011981 flavanones Nutrition 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000002510 keratinocyte Anatomy 0.000 description 3
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 3
- LOYXTWZXLWHMBX-VOTSOKGWSA-N pinocembrin chalcone Chemical compound OC1=CC(O)=CC(O)=C1C(=O)\C=C\C1=CC=CC=C1 LOYXTWZXLWHMBX-VOTSOKGWSA-N 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 3
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- GHISAUFWVUOBIR-UHFFFAOYSA-N 3-phenyl-1-[2,4,6-trihydroxy-3-(3-methyl-6-propan-2-ylcyclohex-2-en-1-yl)phenyl]propan-1-one Chemical compound CC(C)C1CCC(C)=CC1C1=C(O)C=C(O)C(C(=O)CCC=2C=CC=CC=2)=C1O GHISAUFWVUOBIR-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241001674044 Blattodea Species 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 238000006482 condensation reaction Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- SURZCVYFPAXNGN-UHFFFAOYSA-N methyl-carbamic acid ethyl ester Chemical compound CCOC(=O)NC SURZCVYFPAXNGN-UHFFFAOYSA-N 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 229910021653 sulphate ion Inorganic materials 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- GVSPXQVUXHMUMA-MDWZMJQESA-N (e)-3-(3,5-ditert-butyl-4-hydroxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one Chemical compound C1=CC(OC)=CC=C1C(=O)\C=C\C1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 GVSPXQVUXHMUMA-MDWZMJQESA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 150000005207 1,3-dihydroxybenzenes Chemical class 0.000 description 1
- JEPSZTLDPWGHPQ-UHFFFAOYSA-N 1-Phenyl-3-(2,4,6-trihydroxyphenyl)-2-propen-1-one Natural products OC1=CC(O)=CC(O)=C1C=CC(=O)C1=CC=CC=C1 JEPSZTLDPWGHPQ-UHFFFAOYSA-N 0.000 description 1
- MOYGKXMTXFAEKL-UHFFFAOYSA-N 1-cyclohexyl-3-phenylprop-2-en-1-one Chemical compound C1CCCCC1C(=O)C=CC1=CC=CC=C1 MOYGKXMTXFAEKL-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- IUKSYUOJRHDWRR-UHFFFAOYSA-N 2-diazonio-4,6-dinitrophenolate Chemical compound [O-]C1=C([N+]#N)C=C([N+]([O-])=O)C=C1[N+]([O-])=O IUKSYUOJRHDWRR-UHFFFAOYSA-N 0.000 description 1
- LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 description 1
- PQSXNIMHIHYFEE-UHFFFAOYSA-N 4-(1-phenylethyl)benzene-1,3-diol Chemical compound C=1C=C(O)C=C(O)C=1C(C)C1=CC=CC=C1 PQSXNIMHIHYFEE-UHFFFAOYSA-N 0.000 description 1
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 description 1
- KTVKIASZLSYKIA-UHFFFAOYSA-N 5,7-dihydroxy-6-(3-methyl-6-propan-2-ylcyclohex-2-en-1-yl)-2-phenyl-2,3-dihydrochromen-4-one Chemical compound CC(C)C1CCC(C)=CC1C1=C(O)C=C(OC(CC2=O)C=3C=CC=CC=3)C2=C1O KTVKIASZLSYKIA-UHFFFAOYSA-N 0.000 description 1
- 235000007755 Annona Nutrition 0.000 description 1
- 240000006199 Annona purpurea Species 0.000 description 1
- 235000011518 Annona purpurea Nutrition 0.000 description 1
- OSJQDORQBHENIN-UHFFFAOYSA-N C=O.C[U] Chemical compound C=O.C[U] OSJQDORQBHENIN-UHFFFAOYSA-N 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 101000935015 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) N-acetyl-6-hydroxytryptophan oxidase ivoB Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- XFYIHRTWDXNCTA-UHFFFAOYSA-N Eugenin Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)OC1CCC2C(C)(CCC3C2(C)CCC4(C)C5CC(C)(C)CCC5(C)CCC34C)C1C XFYIHRTWDXNCTA-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 241000035890 Helichrysum arenarium Species 0.000 description 1
- 241000131379 Helichrysum cordifolium Species 0.000 description 1
- 244000308760 Helichrysum petiolatum Species 0.000 description 1
- 102100031413 L-dopachrome tautomerase Human genes 0.000 description 1
- 101710093778 L-dopachrome tautomerase Proteins 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- AFJBDWHCOLAFQN-UHFFFAOYSA-N Linderachalcone Natural products CC(C)C1CCC(C)=CC1C1=C(O)C=C(O)C(C(=O)C=CC=2C=CC=CC=2)=C1O AFJBDWHCOLAFQN-UHFFFAOYSA-N 0.000 description 1
- 235000017784 Mespilus germanica Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- AHSGBCHOIWPPDO-UHFFFAOYSA-N Methyllinderatone Natural products COc1cc(O)c2C(=O)CC(Oc2c1C3C=C(C)CCC3C(C)C)c4ccccc4 AHSGBCHOIWPPDO-UHFFFAOYSA-N 0.000 description 1
- 244000182216 Mimusops elengi Species 0.000 description 1
- 235000000560 Mimusops elengi Nutrition 0.000 description 1
- 206010028400 Mutagenic effect Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- FGUBFGWYEYFGRK-HNNXBMFYSA-N Pinocembrin Natural products Cc1cc(C)c2C(=O)C[C@H](Oc2c1)c3ccccc3 FGUBFGWYEYFGRK-HNNXBMFYSA-N 0.000 description 1
- 241000758706 Piperaceae Species 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 101710173694 Short transient receptor potential channel 2 Proteins 0.000 description 1
- 235000007837 Vangueria infausta Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000001203 anti-plasmodial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008436 biogenesis Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 229960002768 dipyridamole Drugs 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000002587 enol group Chemical group 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- SUTUBQHKZRNZRA-UHFFFAOYSA-N eugenin Chemical compound O1C(C)=CC(=O)C=2C1=CC(OC)=CC=2O SUTUBQHKZRNZRA-UHFFFAOYSA-N 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229960005219 gentisic acid Drugs 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 208000000069 hyperpigmentation Diseases 0.000 description 1
- 230000003810 hyperpigmentation Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- LGKJJUMVDIOTCE-UHFFFAOYSA-N linderatone Natural products CC(C)C1CCC(C)=CC1C1=C(O)C=C(O)C2=C1OC(C=1C=CC=CC=1)CC2=O LGKJJUMVDIOTCE-UHFFFAOYSA-N 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 230000003061 melanogenesis Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 231100000243 mutagenic effect Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- AFFLGGQVNFXPEV-UHFFFAOYSA-N n-decene Natural products CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- QCDYQQDYXPDABM-UHFFFAOYSA-N phloroglucinol Chemical compound OC1=CC(O)=CC(O)=C1 QCDYQQDYXPDABM-UHFFFAOYSA-N 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 230000009979 protective mechanism Effects 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- FTIMWVSQXCWTAW-UHFFFAOYSA-N ruthenium Chemical compound [Ru].[Ru] FTIMWVSQXCWTAW-UHFFFAOYSA-N 0.000 description 1
- 229910001925 ruthenium oxide Inorganic materials 0.000 description 1
- WOCIAKWEIIZHES-UHFFFAOYSA-N ruthenium(iv) oxide Chemical compound O=[Ru]=O WOCIAKWEIIZHES-UHFFFAOYSA-N 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 238000011894 semi-preparative HPLC Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 150000003611 tocopherol derivatives Chemical class 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000028973 vesicle-mediated transport Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- 150000003785 γ-tocopherols Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
- C07C49/835—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups having unsaturation outside an aromatic ring
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本發明係有關於新穎的查酮或二氫查酮之單萜衍生物及其作為除色素劑的用途。
Description
本發明係有關於查酮或式(I)之二氫查酮的單萜衍生物在除色素作用之領域中的用途及在美容用或皮膚用組成物內之含其等的植物萃取物。
已揭示三氫查酮之除色素活性。就本活性而言,該等OH基的位置特別重要。2’,4’,6’-三氫查酮(II)顯示對酪胺酸酶之IC50為120μMi(對真菌酪胺酸酶之單酚氧化酶活性。
令人驚訝且非可預期地,本發明者已證明另外經一萜或烯醇基團取代(式I)可大大地增強本活性。本分子類型在植物中很少見。迄今,僅3種藉通式(I)而代表之天然存在的化合物業經文獻揭示:烏藥萜烯二氫查酮(linderatin)(III)、釣樟屬查酮(IV)及甲基-烏藥萜烯二氫查酮(V)。
已自以下離析其等:
-Piper aduncum ii ,葉,胡椒科:(-)-甲基-烏藥萜烯二氫查酮,
-Piper hostmannianum var.Berbicense iii 葉(胡椒科):(-)-甲基-烏藥萜烯二氫查酮
-Lindera umbellata var.membranaceaiv,v及lanceavi,葉vii或樹皮viii,樟科:(+)-烏藥萜烯二氫查酮、釣樟屬查酮ix、甲基-烏藥萜烯二氫查酮。
-Mitrella kentii,樹幹皮,番荔枝科:(-)-烏藥萜烯二氫查酮x
本發明者首先自鷹草永久花(Helichrysum gymnocephalum(DC)(Humbert)之地上部份離析一具有緊密關聯的結構之化合物-裸查酮(gymnochalcone)(VI)或α-烯醇松屬素查酮。
本發明者亦首先自樹胡椒(Piper aduncum)的葉部離析烏藥萜烯二氫查酮。
就所述的生物活性而言,(-)烏藥萜烯二氫查酮對一癌細胞株(肺)x具有細胞毒殺性。而(-)-甲基-烏藥萜烯二氫查酮具有一抗瘧原蟲活性iii。
上述化合物中無一種業經揭示具有除色素活性。
依據本發明之一實施例,係特地提出一種富含一或多下式(I)分子的鷹草永久花(DC)(Humbert)之萃取物:
其中為一單鍵或雙鍵;R1=H或CH3;而R2=H或OH。
本發明之第一目標因此係提供一作為除色素劑的富含一或多種下式(I)之分子之鷹草永久花(DC)(Humbert)的萃取物
其中為一單鍵或雙鍵;R1=H或CH3;而R2=H或OH R1較佳為H
較佳,為一單鍵,R1=H且R2=H或OH,或為一單鍵,R1=H或CH3且R2=H。
更佳,為一單鍵,R1=H且R2=H,亦即根據本發明之該萃取物富含烏藥萜烯二氫查酮。
更佳,為一雙鍵,R1=H且R2=OH,亦即根據本發明之該萃取物富含裸查酮。此萃取物特別有利,因為本發明者已驚訝地發現裸查酮於其中經過一段時間後仍具安定性。事實上,一旦藉麥可(Michael)型反應而添加一羥基至該羰基內的1,4-位置上時(其會導致該等查酮之不安定),在本情況下並未發現查酮轉化成黃烷酮的環化反應。就純化裸查酮而言,可發現此種環化反應。因此較佳以鷹草永久
花之萃取物的形式使用裸查酮。
本發明者已證明本發明之此種鷹草的萃取物之除色素活性特別有利。本發明者亦證明由於在相同條件下製成之沙生臘菊品種永久花(Helichrysum arenarium)、心葉永久花(Helichrysum cordifolium)及頭狀永久花(Helichrysum stoechias)的萃取物雖然皆富含類黃酮及查酮,但是對於在B16鼠黑細胞上合成黑色素的作用並未顯示任何抑制活性,所以此種活性尤其為該鷹草永久花物種所特有。
根據本發明之該萃取物的每100克萃取物固體較佳包含一或多種含量介於0.1與30克間、較佳介於0.1與10克、最佳介於0.1與5克間之式I分子。
有利的是,根據本發明之該萃取物係得自鷹草永久花(DC)(Humbert)(菊科(Asteraceae),syn Stenocline gymnocephala)之地上部份。其係遵照熟悉本項技藝者熟知的傳統步驟自本植物製成。
可以於該植物的成長之5個不同階段採收鷹草永久草(DC)(Humbert)的地上部份,這5個階段為營養期、預開花期、開花開始期、開花期、結果實期。有利的是,根據本發明之該萃取物係得自於該結果實期(較佳於該結果實期結束時)之鷹草永久花(DC)(Humbert)的地上部份。
在經一有機溶劑萃取前,將該較佳經乾燥的植物磨碎,該有機溶劑可以是酯(乙酸乙酯、乙酸異丙酯)、醇(甲醇、乙醇、丙醇、異丙醇、丁醇)、酮(甲基乙基酮、二甲基酮、甲基異丁基酮)、鹵化烴(氯仿、二氯甲烷)、水或呈任
何可混溶比例之這些溶劑的混合物。
以介於約1/1與約1/20間的植物/溶劑比進行該萃取步驟且可重複2至3次。該萃取溶劑之溫度範圍可自室溫至高於環境溫度、高至所使用該溶劑的沸騰溫度。該植物與溶劑的接觸時間為自介於約30分鐘與約72小時之間。
接著進行固/液分離,其中係,例如藉過濾或離心法而自該溶劑分離植物。
所獲得該濾液可:-藉完全蒸發該溶劑而直接乾燥以獲得最終萃取物,-以液體形式貯存在該萃取溶劑內,其限制條件為其可以與其目的用途相容。在本情況下,其可藉一蒸發步驟而或多或少地濃縮,-經濃縮。可藉熟悉本項技藝者已知的技術,諸如在介於2種非可混溶溶劑之間進行液/液萃取、吸收至一載劑(諸如氧化矽)、一離子交換樹脂上等,而進行相關化合物的本濃縮步驟。
一先後藉萃取、固/液分離、及乾燥而獲得之萃取物包括該式I內所包含的一質量之化合物(群),其含量為每100克萃取物乾燥物質之介於0.1與30克之間、較佳介於0.1與10克之間、最佳介於0.1與5克之間。若該萃取物維持在一溶液內,該液態萃取物之乾燥物質的含量係每100毫克之介於0.1與80克之間。
本發明之另一目標係有關於用於製造一根據本發明的萃取物之方法。
本發明之另一目標係有關於一富含一或多下式(I)分子之植物源之萃取物作為一除色素劑的美容用途、或一下式(I)分子作為一除色素劑的美容用途:
其中為一單鍵或雙鍵;R1=H或CH3;且R2=H或OH R1較佳為H。
較佳,為一雙鍵,R1=H且R2=H或OH,或為一單鍵,R1=H或CH3且R2=H。
更佳,為一雙鍵,R1=H且R2=OH,亦即本發明係有關於一富含裸查酮之植物源之萃取物的美容用途;或該裸查酮分子的美容用途。
更佳,為一單鍵,R1=H且R2=H,亦即本發明係有關於一富含烏藥萜烯二氫查酮之植物源之萃取物的美容用途;或該烏藥萜烯二氫查酮分子的美容用途。
最佳,本發明係有關於含一或多式1分子之一植物源之萃取物的美容用途,該式1分子的含量為每100克萃取物乾燥物質之介於0.1與30克之間、較佳介於0.1與10克之間、最佳介於0.1與5克之間。
該含一或多式(I)分子的萃取物較佳為本發明之一萃取物、或一屬於包括Piper hostmannianum、Piper hispidum、樹胡椒(Piper aduncum)、Lindera aggregata、Lindera umbellata、Lindera glauca、Mitrella mesnyi、Mitrella kentii之永久花屬、胡椒屬、釣樟(Lindera)或麥螺屬(Mitrella)之植物的萃取物。
當經合成時,烏藥萜烯二氫查酮及甲基-烏藥萜烯二氫查酮最佳呈純形式用於根據本發明的美容品,因為在此形式中其等具安定性。
另一方面,優於純裸查酮的美容品用途,富含裸查酮之鷹草永久花之萃取物的美容用途較有利,因為於其中其安定性高於呈該純形式。
有利的是,根據本發明之美容用途係用於漂白及/或增亮皮膚及/或短鬚及/或頭髮,減少及/或移除皮膚的老人斑或減少及/或移除可藉UV而誘發的帶褐色之色斑或黃竭斑(chloasma)。
該式(I)分子及/或含其等之作為除色素劑的植物萃取物亦業經證明對於控制及/或抑制造成色素沈著之黑色素的產生具良好能力,因此有利於某些由於表皮的色素沈著過度所造成之無美感的色斑(尤其皮膚上的老人斑)之除色
素作用。
可藉化學或生化合成法或自一植物萃取物獲得根據本發明的式(I)分子。
該式(I)分子較佳選自以下所組成的群組:
-裸查酮(式VI),其中為一雙鍵,R1=H且R2=OH,-烏藥萜烯二氫查酮(式III),其中為一單鍵,R1=H且R2=H,-烏藥查酮(linderachalcone)(式IV),其中為一雙鍵,R1=H且R2=H,-甲基烏藥萜烯二氫查酮(式V),其中為一單鍵,R1=CH3且R2=H。
就其中該分子為裸查酮的情況而言,該植物源可較佳為鷹草永久花(DC)(Humbert);且更佳為鷹草永久花(DC)(Humbert)的地上部份,且又更佳為於結果實期所採收的鷹草永久花(DC)(Humbert)之地上部份。
就其中該分子為烏藥萜烯二氫查酮的情況而言,其可較佳藉化學合成法而獲得。
就其中該分子為一植物源的烏藥萜烯二氫查酮的情況而言,該植物源較佳可以是Lindera umbellata var.membranacea及lancea;且更佳為其葉部或樹皮。
本發明之另一目標係有關於含一富含一或多下式(I)分子之植物源的萃取物、或一或多下式(I)分子作為一活性成份之美容用或皮膚用組成物:
其中為一單鍵或雙鍵;R1=H或CH3;且R2=H或OH。
R1較佳為H。較佳,為一雙鍵,R1=H且R2=H或OH,或為一單鍵,R1=H或CH3且R2=H。
更佳,為一雙鍵,R1=H且R2=OH,亦即本發明係有關於一富含裸查酮之植物萃取物、或該裸查酮分子作為一有效成份的美容用或皮膚用組成物。
更佳,為一單鍵,R1=H且R2=H,亦即本發明係有關於一富含烏藥萜烯二氫查酮之植物萃取物、或該烏藥萜烯二氫查酮作為一活性成份的美容用或皮膚用組成物。
最佳,本發明係有關於含一或多式I分子的植物源之萃取物作為一活性成份的本發明之美容用或皮膚用組成物,該式I分子的含量為每100克萃取物乾燥物質之介於0.1與30克之間、較佳介於0.1與10克之間、最佳介於0.1與5克之間。
有利的是,該萃取物為本發明之一萃取物或屬於包括Piper hostmannianum、Piper hispidum、Piper aduncum、Lindera aggregata、Lindera umbellata、Lindera glauca、Mitrella mesnyi、Mitrella kentii之永久花屬、胡椒屬、釣樟屬或麥螺屬之植物的一萃取物。
本發明之另一目標係有關於一作為一藥物之根據本發明的皮膚用組成物。
本發明之另一目標係有關於一用於使皮膚及/或鬚及/或髮去除色素的根據本發明之皮膚用組成物。
本發明之另一目標係有關於用以治療皮膚之色素沈著過度之根據本發明的皮膚用組成物。
有利的是,該根據本發明之美容組成物係用於減少及/或移除及/或預防皮膚上之色斑。
有利的是,該根據本發明之美容組成物係用於漂白及/或增亮皮膚及/或短鬚及/或頭髮。
可使用該式I分子及/或一含根據本發明之此種分子的植物萃取物以使皮膚色調均等:其特徵為均勻、更淺色、更透明、更明亮的皮膚色調。因此可改善皮膚色調的明亮度。
有利的是,該根據本發明之美容組成物係用於使皮膚色調均等。
不管敏感性皮膚的性質(乾性、正常、油性),使用該根據本發明之組成物所獲得的優點尤其有利於敏感性皮膚,且更特別有利於暗沈且缺乏明亮度的敏感性皮膚。
有利的是,該根據本發明之美容組成物係用於敏感性皮膚。
該式(I)分子及/或該等含根據本發明之式(I)分子的植物萃取物係有利於:-減少及/或移除色斑,諸如由於致炎原的應激物引起之色素沈著過度的色斑,例如UV誘發的帶褐色色斑;或減少及/或移除黃褐斑;-減少及/或抑制色素沈著之主因的黑色素之產生。
除了該活性成份(群)外,該等根據本發明之美容及/或皮膚用組成物可包括一生理上可接受介質;亦即其係與皮膚及/或頭皮、黏膜、頭髮、短鬚及/或眼睛相容。
該根據本發明之美容或皮膚用組成物較佳含式(I)分子作為一活性成份,該式(I)分子的含量為每100克該組成物之介於10毫克與5克之間、且更佳介於100毫克與1克之間。
該根據本發明之美容或皮膚用組成物較佳含本發明該植物萃取物作為一活性成份,該植物萃取物的含量為每100克該組成物之介於0.1克與10克之間、且更佳介於1克與5克之間。
可有利地呈常用於適於局部或口服用途之美容及皮膚用領域的任何劑型提供該根據本發明之美容及/或皮膚用組成物。
較佳,該局部用形式可特別呈以下形式:-一可視需要選用的膠化水性或氫醇系溶液、-一可視需要選用的雙相洗劑型分散液、-一水包油或油包水或多乳液、-一水性凝膠,且可以呈漿液(serum)、乳膏、凝膠、軟膏、乳、洗劑、糊或泡沫之形式提供。其亦可以呈氣溶膠或呈固體(其包括,例如呈棒狀物形式)形式施用。
本發明的優點之一在於即便在敏感性皮膚(不管其性質(乾性、正常、油性))上,該等根據本發明之組成物仍顯示良好的皮膚耐受性。
本組成物亦可呈口服劑型提供,諸如錠劑、膠囊、用於可飲用懸浮液的散劑。
該組成物亦可包含常用於預期的應用之任何組份。這些組份包括水、溶劑、礦物質、動物及/或植物油、蠟、色料、化學或礦物濾劑、抗氧化劑、填料、表面活化劑、安定劑、防腐劑、芳香劑、及著色劑。
該組成物亦可合併一根據本發明之除色素活性成份與熟悉本項技藝者所熟知的其它除色素活性成份,其包括:維生素C衍生物、間苯二酚衍生物(更特定地,4-正-丁基間苯二酚或4-(1-苯基乙基)苯-1,3-二醇、對苯二酚、熊果苷(arbutin)、麴酸及其衍生物、生育酚(tocopherol)衍生物。
亦可藉該組成物欲施用的皮膚及/或短鬚及/或頭髮之特定需求以及藉該根據本發明之組成物所欲的性質及稠度
而決定該一或多種成份的選用及/或數量。
本發明之另一目標係有關於一用於漂白及/或增亮皮膚及/或短鬚及/或頭髮的美容方法,其包括施加一根據本發明之美容組成物至該皮膚及/或短鬚及/或頭髮。
本發明之另一目標係有關於一用於減少及/或移除及/或預防皮膚上的色斑之美容方法,其包括施加一如本發明所定義之美容組成物至該皮膚上。
本發明之另一目標係有關於下式(VI)分子
其較佳藉化學或生化合成法、或自一植物萃取物而獲得。
可參考以下非限制性實例(其等係為根據本發明之該等美容及/或皮膚用組成物的具體實施例)更佳地瞭解本發明。
在回流下,使5公斤乾燥的地上部份經35及25升之95%乙醇萃取兩次。濃縮並乾燥該等合併濾液。該呈褐色糊形式的所獲得萃取物含有0.28克裸查酮/每100克固體。
遵照文獻xv,xvi內所揭示的以下反應圖解,藉雙步驟合成法而獲得該烏藥萜烯二氫查酮
在ZnCl2及HCl氣體之無水醚的存在下,藉根皮三酚(2,4,6-三羥苯)與氫桂皮腈之縮合反應而進行分子(VII)的合成。
然後,在對-甲苯磺酸之無水苯的存在下,藉α-茴香萜(其係購自Sigma Aldrich)(95%)與該分子(VII)的縮合反應而獲得烏藥萜烯二氫查酮。
就各方面而言,所形成該烏藥萜烯二氫查酮與文獻xvi內所揭示的天然產物相同。
將該等地上部份乾燥並磨碎,然後經乙酸乙酯萃取。在經庚烷、二氯甲烷及丙酮溶析的中壓氧化矽柱上分餾此萃取物,在TLC分析及相同餾份的組合後,得到11種餾份。然後在具有一乙腈/水+0.1%乙酸之梯度的C-18接枝之氧化矽上分餾活性餾份8,導致式VI裸查酮之離析(0.02%產率/乾植物)。
藉呈陽離子模式之電噴源質譜測定法而進行之分析得
到該加成物[M+Na]+=431.3且[2M+Na]+=839.4。在陰離子模式內,發現[M-H]-=407.3。因此該化合物的質量為408克/莫耳。在MS/MS中,係釋於一152片段,其相當於α-烯醇(或對--1-烯-8-醇)。
單-及雙-維質子及碳NMR分析可確認呈相對構形的結構,其具有以下實驗式C25H28O5。
除了在3’位置不同外,該NMR輪廓具有2’,4’,6’-三羥查酮(II)的特徵。除了8”、9”及10”位置不同外,其亦很接近烏藥查酮的特徵,其中由於於8”位置之一羥基官能基的存在,所以這些位置進一步經去遮蔽。
將該等葉部乾燥並磨碎,然後於室溫下在黑暗中藉浸解而經乙醇96(1重量/10體積)萃取,費時15小時。在一已經過庚烷、乙酸乙酯及甲酯溶析的中壓氧化矽柱上分餾本萃取物(17%產率)在TLC分析及相同餾份的組合後,得到21種餾份。接著藉在具有一乙腈/水之梯度的C-18接枝之氧化矽上的半製備HPLC而分餾餾份3及4,因此可離析式V之甲基烏藥萜烯二氫查酮(13%產率/萃取物,2.2%乾植物)。
該等NMR及質譜測定法的數據與用於甲基烏藥萜烯二氫查酮ii的文獻內所揭示的數據一致。
黑細胞為星形狀細胞,其係以較小的比例包含在表皮之基層內。其主要功用為確保黑色素生成,該黑色素生成作用為一如下的作用:黑色素被合成為特異細胞器(亦即黑素體(melanosome)),然後經由其等之樹枝狀擴張而傳輸並分佈至鄰近的角質細胞。此種與角質細胞之接觸可以使皮膚色素沈著,其係為表皮對抗紫外線之致突變效應的保護機制。各黑細胞係與約36個角質細胞有關,因此可形成一《表皮-黑色素單元》。
黑色素生成係由一系列的酶催及自發反應所組成且具有酪胺酸作為先質。參與本作用的三種主要酶為酪胺酸酶、及酪胺酸酶關聯性蛋白質1及2(TRP1及2)xi。
已知某些外源性分子可下調黑色素生成作用。氫醌可藉對酪胺酸酶提供一基質以改變其活性而抑制黑色素合成xii。含有氫醌之熊果苷係以相同方式作用。麴酸可藉抑制UV誘發的色素沈著過度而降低酪胺酸酶的活性xiii。維生素C可藉預防黑色素的氧化性著色而抑制酪胺酸酶,而且亦可像強
效的還原劑一般作用。維生素A可降低酪胺酸酶及TRP-2的表現性xiv。
我們已研發一用於測定黑色素合成的試驗,其係藉對鼠的黑色瘤細胞株B16-F10進行比色檢定。本檢定可測試活性成份的除色素能力。
iBioorganic & Medicinal Chemistry 13,2005,433-441
iiOrjala J.et al.New monoterpene-substituted dihydrochalcones from Piper aduncum.Helv.Chem.Acta 1993,76,1481-1488
iiiPortet B.et al.,Activity-guided isolation of antiplasmodial dihydrochalcones and flavanones from Piper hostmannianum var.berbicense.Phytochemistry 2007,68,1312-1320
ivIchino K.et al.,Revised structures of Linderatone and methyllinderatone.Heterocyctes 1990,31,549-553.
vIchino K.et al.,Studies on the flavonoid components of Lindera umbellata THUNB.Var.membranacea(MAXIM.)MOMIYAMA Chem Pharm Bull 1989 37,944-947
viIchino K.et al.,A new flavanone,neolinderatone,from Lindera umbellata THUNB.Var.Lancea MOMIYAMA.Chem Pharm Bull 1989,37,1426-1427
vii Ichino K.et al.,Two novel flavonoids from the leaves of Lindera umbellata var.Lancea and L.umbellata.Tetrahedron 1988,44,3251-3260
viiiShimomura H.et al.,A chalcone derivative from the bark of Lindera umbellata.Phytochemistry 1988,27,3937-3939
ixIchino K.,Two flavonoids from two Lindera umbellata varieties.Phytochemistry 1989,28,955-956
xBenosman A.et al.,New terpenylated dihydrochalcone derivatives isolated from Mitrella kentii.J.Nat.Prod.1997,60,921-924.
xiJimbow,K.et al.Intracellular vesicular trafficking of tyrosinase gene family protein in eu-and pheomelanosome biogenesis.Pigment Cell Res.2000.;13 Suppl 8.:110.-7. 13 Suppl 8,110-117.
xiiCurto,E.V.et al.Inhibitors of mammalian melanocyte tyrosinase:in vitro comparisons of alkyl esters of gentisic acid with other putative inhibitors.Biochem.Pharmacol.1999,57,663-672.
xiiiKuwabara,Y.et al.Topical Application of gamma-Tocopherol Derivative Prevents UV-Induced Skin Pigmentation.Biol.Pharm.Bull.2006.Jun.;29.(6.):1175.-9. 29,1175-1179
xivOrtonne,J.P.and Bissett,D.L.(2008)J.Investig.Dermatol.Sym p.Proc.2008.Apr;13(1):10-4. 13,10-14
xvKamarul,A.M et al.Tetrahedron 59(2003),6113
xviCrombie L,et al.J.Chem.Soc.Perkin Trans.1988,1251
Claims (22)
- 一種富含一或多下式(I)分子的鷹草永久花(Helichrysum gymnocephalum(DC)Humbert)之萃取物:
其中為一單鍵或雙鍵;R1=H或CH3;且R2=H或OH。 - 如申請專利範圍第1項之萃取物,其包含每100克乾物質在0.1與30克間之數量之一或多該式I分子。
- 一種用於製造如申請專利範圍第1或2項之萃取物的方法,其包括以下連續步驟:-採收、乾燥並研磨鷹草永久花(Helichrysum gymnocephalum(DC)Humbert)(菊科,syn.Stenocline gymnocephala)的地上部份,-以介於約1/1與約1/20間的植物/溶劑比之有機溶劑萃取得自先前步驟之該經研磨的物質,-藉由例如過濾法或離心法而使固體/液體分離。
- 一種富含一或多下式(I)分子之植物源之萃取物的美容用途或一種下式(I)分子的美容用途:
其中為一單鍵或雙鍵;R1=H或CH3;且R2=H或OH;其用作為除色素劑。 - 如申請專利範圍第4項之用途,其特徵在於該富含一或多式(I)分子的植物源之萃取物為如申請專利範圍第1或2項中之萃取物。
- 如申請專利範圍第4項之用途,其特徵在於該富含一或多式(I)分子的植物源之萃取物為屬於麥稈菊屬(Helichrysum)、胡椒屬(Piper)、釣樟屬(Lindera)或麥螺屬(Mitrella)之植物的萃取物,其包括:鷹草永久花(Helichrysum gymnocephalum(DC)Humbert)、Piper hostmannianum、樹胡椒(P.aduncum)、P.hispidum、天台烏藥(Lindera aggregata)、白葉釣樟(L.glauca)、大葉釣樟(L.umbellatta)、Mitrella mesnyi、M.kentii。
- 如申請專利範圍第4至6項中任一項之用途,其特徵在於為雙鍵 R1=H;且R2=OH。
- 如申請專利範圍第4至6項中任一項之用途,其特徵在於為單鍵R1=H;且R2=H。
- 如申請專利範圍第4至8項中任一項之用途,其係用於漂白及/或增亮該皮膚及/或鬚及/或髮。
- 如申請專利範圍第4至8項中任一項之用途,其係用於減少及/或移除該皮膚上的老人斑。
- 如申請專利範圍第4至8項中任一項之用途,其係用於減少及/或移除可藉UV而誘發的帶褐色之色素或黃褐斑。
- 一種美容或皮膚用組成物,其包含一作為活性成份之富含一或多下式(I)分子之植物源的萃取物或一或多下式(I)分子:
其中為一單鍵或雙鍵;R1=H或CH3;且 R2=H或OH。 - 如申請專利範圍第12項之美容或皮膚用組成物,其特徵在於該富含一或多式(I)分子之植物源的萃取物係如申請專利範圍第1至2項中任一項之萃取物或屬於麥稈菊屬(Helichrysum)、胡椒屬(Piper)、釣樟屬(Lindera)或麥螺屬(Mitrella)之植物的萃取物,其包括鷹草永久花(Helichrysum gymnocephalum(DC)Humbert)、Piper hostmannianum、Piper hispidum、樹胡椒(P.aduncum)、天台烏藥(Lindera aggregata)、白葉釣樟(Lindera glauca)、大葉釣樟(Lindera umbellatta)、Mitrella mesnyi、Mitrella kentii。
- 如申請專利範圍第12或13項之皮膚用組成物,其係作為一藥物使用。
- 如申請專利範圍第12或13項之皮膚用組成物,其係用於該皮膚及/或鬚及/或髮的去除色素作用。
- 如申請專利範圍第12或13項之皮膚用組成物,其係用以該皮膚之色素沈著過度的治療。
- 如申請專利範圍第12或13項之美容組成物的用途,其係用於減少及/或移除及/或預防該皮膚上的色素沉著。
- 如申請專利範圍第12或13項之美容組成物的用途,其係用於漂白及/或增亮該皮膚及/或鬚及/或髮。
- 一種用於漂白及/或增亮該皮膚及/或鬚及/或髮的美容方法,其包括施用如申請專利範圍第12或13項所定義之美容組成物至該皮膚及/或鬚及/或髮。
- 一種用於減少及/或移除及/或預防該皮膚上之色素沉著的美容方法,其包括施用如申請專利範圍第12或13項所定義之美容組成物至該皮膚。
- 一種下式(VI)之分子:
- 如申請專利範圍第21項之分子,其特徵在於其係藉化學或生化之合成法或自植物萃取物而獲得。
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1150386A FR2970416B1 (fr) | 2011-01-18 | 2011-01-18 | Nouveaux derives monoterpeniques de chalcone ou dihydrochalcone et leur utilisation comme depigmentants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201309637A true TW201309637A (zh) | 2013-03-01 |
| TWI582069B TWI582069B (zh) | 2017-05-11 |
Family
ID=44310851
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW101101715A TWI582069B (zh) | 2011-01-18 | 2012-01-17 | 新穎的查酮或二氫查酮之單萜衍生物及其作為除色素劑的用途 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US9629786B2 (zh) |
| EP (1) | EP2665484B1 (zh) |
| JP (1) | JP6297333B2 (zh) |
| KR (1) | KR101916977B1 (zh) |
| CN (1) | CN103313722B (zh) |
| AR (1) | AR084874A1 (zh) |
| AU (1) | AU2012208626B2 (zh) |
| BR (1) | BR112013018287A2 (zh) |
| CA (1) | CA2823629C (zh) |
| ES (1) | ES2653148T3 (zh) |
| FR (1) | FR2970416B1 (zh) |
| IL (1) | IL227447A (zh) |
| MA (1) | MA34840B1 (zh) |
| MX (1) | MX360027B (zh) |
| PL (1) | PL2665484T3 (zh) |
| PT (1) | PT2665484T (zh) |
| RU (1) | RU2595860C2 (zh) |
| TN (1) | TN2013000283A1 (zh) |
| TW (1) | TWI582069B (zh) |
| WO (1) | WO2012098134A1 (zh) |
| ZA (1) | ZA201305458B (zh) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6017259B2 (ja) * | 2012-10-12 | 2016-10-26 | 花王株式会社 | エンドセリン作用抑制剤 |
| DE102013204070A1 (de) * | 2013-03-11 | 2014-09-11 | Beiersdorf Ag | Verwendung kosmetisch oder dermatologisch unbedenklicher substituierter Michael-Akzeptoren zur Verhinderung, Verminderung oder Prophylaxe der Tyrosinaseaktivität der menschlichen Haut und/oder deren Aufhellung |
| CN103553894B (zh) * | 2013-11-05 | 2016-01-06 | 辽宁石油化工大学 | 一种1,3-二苯基-1-丙酮的合成方法 |
| JP7344125B2 (ja) * | 2017-03-30 | 2023-09-13 | エフ. ホフマン-ラ ロシュ アーゲー | 細菌感染の治療及び予防のための新規ピリド[2,3-b]インドール化合物 |
| FR3074421B1 (fr) | 2017-12-01 | 2020-07-17 | Pierre Fabre Dermo-Cosmetique | Extrait d'helichrysum gymnocephalum pour le traitement et/ou la prevention des dermatoses inflammatoires |
| KR102408169B1 (ko) * | 2020-08-28 | 2022-06-14 | 주식회사 포스코 | 오카닌을 함유하는 항노화 또는 피부재생용 조성물 |
| FR3123568B1 (fr) | 2021-06-03 | 2023-06-09 | Laboratoires M&L | Utilisation cosmetique d’un extrait huileux de dreches d'immortelle comme agent eclaircissant de la peau |
| FR3142089B1 (fr) | 2022-11-18 | 2024-11-08 | Laboratoires M&L | Utilisation cosmétique d’un extrait d'immortelle comme agent éclaircissant de la peau |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3150841B2 (ja) * | 1994-04-06 | 2001-03-26 | ポーラ化成工業株式会社 | 皮膚外用剤 |
| JP3650147B2 (ja) * | 1994-06-27 | 2005-05-18 | ポーラ化成工業株式会社 | メラニン生成阻害剤及び皮膚外用剤 |
| JPH0812566A (ja) * | 1994-06-29 | 1996-01-16 | Shiseido Co Ltd | チロシナーゼ活性阻害剤 |
| JP3993936B2 (ja) * | 1998-05-22 | 2007-10-17 | 一丸ファルコス株式会社 | メラニン生成抑制剤及び化粧料組成物 |
| MXPA06013705A (es) * | 2004-05-28 | 2007-02-13 | Unigen Pharmaceuticals Inc | Diarilalcanos como potentes inhibidores de enzimas binucleares. |
| JP2006124322A (ja) * | 2004-10-28 | 2006-05-18 | Takasago Internatl Corp | ヒアルロニダーゼ阻害剤、および該ヒアルロニダーゼ阻害剤を含有する皮膚外用組成物および口腔用組成物 |
| FR2884250B1 (fr) * | 2005-04-06 | 2010-01-08 | Coletica | Utilisation des aurones pour leur activite depigmentante ou inhibitrice de la melanogenese dans des compositions cosmetiques ou dermatologiques |
| FR2903014B1 (fr) * | 2006-06-30 | 2008-09-26 | Occitane L | Composition cosmetique a base d'acide gras polyinsatures et ses utilisations |
| JP2008156325A (ja) * | 2006-12-26 | 2008-07-10 | Shiseido Co Ltd | 皮膚外用剤および美白剤 |
| JP2010100554A (ja) * | 2008-10-23 | 2010-05-06 | B & C Laboratories Inc | メラニン生成抑制剤 |
| JP2010159220A (ja) * | 2009-01-07 | 2010-07-22 | Kao Corp | ドーパオキシダーゼ活性抑制剤および細胞増殖活性促進剤 |
| US20110159125A1 (en) * | 2009-12-29 | 2011-06-30 | Avon Products, Inc. | CGRP Compositions and Uses Thereof |
-
2011
- 2011-01-18 FR FR1150386A patent/FR2970416B1/fr not_active Expired - Fee Related
-
2012
- 2012-01-17 AR ARP120100153A patent/AR084874A1/es not_active Application Discontinuation
- 2012-01-17 TW TW101101715A patent/TWI582069B/zh not_active IP Right Cessation
- 2012-01-18 EP EP12700483.6A patent/EP2665484B1/en active Active
- 2012-01-18 MX MX2013008133A patent/MX360027B/es active IP Right Grant
- 2012-01-18 PT PT127004836T patent/PT2665484T/pt unknown
- 2012-01-18 KR KR1020137021570A patent/KR101916977B1/ko not_active Expired - Fee Related
- 2012-01-18 PL PL12700483T patent/PL2665484T3/pl unknown
- 2012-01-18 AU AU2012208626A patent/AU2012208626B2/en not_active Ceased
- 2012-01-18 CN CN201280004986.9A patent/CN103313722B/zh active Active
- 2012-01-18 MA MA36134A patent/MA34840B1/fr unknown
- 2012-01-18 US US13/823,681 patent/US9629786B2/en not_active Expired - Fee Related
- 2012-01-18 ES ES12700483.6T patent/ES2653148T3/es active Active
- 2012-01-18 JP JP2013549797A patent/JP6297333B2/ja not_active Expired - Fee Related
- 2012-01-18 WO PCT/EP2012/050669 patent/WO2012098134A1/en not_active Ceased
- 2012-01-18 CA CA2823629A patent/CA2823629C/en not_active Expired - Fee Related
- 2012-01-18 RU RU2013135683/15A patent/RU2595860C2/ru active
- 2012-01-18 BR BR112013018287A patent/BR112013018287A2/pt not_active IP Right Cessation
-
2013
- 2013-07-02 TN TNP2013000283A patent/TN2013000283A1/fr unknown
- 2013-07-11 IL IL227447A patent/IL227447A/en active IP Right Grant
- 2013-07-19 ZA ZA2013/05458A patent/ZA201305458B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2653148T3 (es) | 2018-02-06 |
| MA34840B1 (fr) | 2014-01-02 |
| US20130177515A1 (en) | 2013-07-11 |
| MX360027B (es) | 2018-10-18 |
| RU2595860C2 (ru) | 2016-08-27 |
| JP6297333B2 (ja) | 2018-03-20 |
| MX2013008133A (es) | 2013-09-13 |
| EP2665484B1 (en) | 2017-11-01 |
| KR101916977B1 (ko) | 2018-11-08 |
| WO2012098134A1 (en) | 2012-07-26 |
| TWI582069B (zh) | 2017-05-11 |
| TN2013000283A1 (en) | 2015-01-20 |
| FR2970416B1 (fr) | 2013-02-22 |
| ZA201305458B (en) | 2015-01-28 |
| US9629786B2 (en) | 2017-04-25 |
| IL227447A0 (en) | 2013-09-30 |
| CN103313722B (zh) | 2016-04-27 |
| IL227447A (en) | 2017-10-31 |
| CN103313722A (zh) | 2013-09-18 |
| AR084874A1 (es) | 2013-07-10 |
| NZ613331A (en) | 2015-08-28 |
| HK1185267A1 (zh) | 2014-02-14 |
| PL2665484T3 (pl) | 2018-04-30 |
| CA2823629C (en) | 2021-07-06 |
| AU2012208626B2 (en) | 2017-03-30 |
| FR2970416A1 (fr) | 2012-07-20 |
| KR20140012059A (ko) | 2014-01-29 |
| CA2823629A1 (en) | 2012-07-26 |
| BR112013018287A2 (pt) | 2016-11-16 |
| JP2014508137A (ja) | 2014-04-03 |
| PT2665484T (pt) | 2018-02-05 |
| RU2013135683A (ru) | 2015-02-27 |
| EP2665484A1 (en) | 2013-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI582069B (zh) | 新穎的查酮或二氫查酮之單萜衍生物及其作為除色素劑的用途 | |
| US20020016358A1 (en) | Cosmetic composition | |
| AU2012208626A1 (en) | Monoterpene derivatives of chalcone or dihydrochalcone and their use as depigmenting agents | |
| WO2008147022A1 (en) | Anti-wrinkle composition for external applications to the skin containing biflavonoid derivatives | |
| JP4992164B2 (ja) | 化粧料組成物 | |
| CN115038426B (zh) | 调料九里香提取物及其在化妆品中的应用 | |
| CN102186457B (zh) | 包含源自红果山胡椒的提取物、部分或化合物的皮肤增白组合物 | |
| KR101903732B1 (ko) | 배향초 추출물의 에틸아세테이트 분획물 또는 이로부터 분리된 화합물을 유효성분으로 함유하는 피부 미백용 조성물 | |
| KR102522196B1 (ko) | 홍화씨유 가수분해물과 삼백초 추출물의 혼합물을 유효성분으로 함유하는 피부미백용 조성물 | |
| KR102325393B1 (ko) | 소계 추출물의 생물전환물을 유효성분으로 함유하는 피부 미백용 화장료 조성물 | |
| KR101481884B1 (ko) | 코보페놀 a를 유효성분으로 포함하는 피부 미백용 조성물 | |
| KR20190079338A (ko) | 개나리 꽃 추출물의 분획물을 유효성분으로 포함하는 화장료 조성물 | |
| KR100482695B1 (ko) | 베타-카르볼린 유도체 또는 그를 함유한 고련피 추출물을유효성분으로 하는 피부 미백용 조성물 | |
| CN100352825C (zh) | 苦竹有效成分提取物的用途 | |
| KR102491296B1 (ko) | 배과피를 이용한 피부 미백용 화장료 조성물 | |
| KR101191992B1 (ko) | 강활 추출물 또는 비사볼란겔론 화합물을 유효성분으로 포함하는 피부 미백용 조성물 | |
| KR102481996B1 (ko) | 로스팅 삼백초 추출물을 유효성분으로 포함하는 피부개선용 화장료 조성물 | |
| JP4261413B2 (ja) | メラニン産生抑制剤 | |
| JP2005247736A (ja) | メラニン産生促進剤 | |
| HK1185267B (zh) | 查尔酮或二氢查尔酮的单萜衍生物以及它们作为脱色剂的用途 | |
| KR20240116413A (ko) | 파이퍼 베틀 잎 추출물을 유효성분으로 포함하는 멜라노파지 유도용 조성물 | |
| NZ613331B2 (en) | Monoterpene derivatives of chalcone or dihydrochalcone and their use as depigmenting agents | |
| KR20200006515A (ko) | 초피나무 추출물 또는 그 분획물을 유효성분으로 함유하는 항염, 주름개선, 미백용 화장료 조성물 및 그 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |